ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,488Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 3593

$983K Total Retail Price of All Prescriptions

Rank: 137 out of 3593

813 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 813 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 813 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 21,845 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,973 1,735 1 1
LISINOPRIL 1,354 1,213 2 2
AMLODIPINE BESYLATE 1,005 876 3 3
OMEPRAZOLE 908 712 4 5
FENOFIBRATE 836 633 5 39
LEVOTHYROXINE SODIUM 765 658 6 4
METFORMIN HCL 762 592 7 6
ATENOLOL 752 625 8 11
ALENDRONATE SODIUM 713 635 9 22
GABAPENTIN 629 454 10 16
HYDROCODONE-ACETAMINOPHEN 607 452 S3 11 7
DOXAZOSIN MESYLATE 569 541 12 63
FUROSEMIDE 540 450 13 9
METOPROLOL SUCCINATE 479 425 14 19
LOSARTAN POTASSIUM 395 376 15 14
PRAVASTATIN SODIUM 376 308 16 13
ALPRAZOLAM 345 285 17 37
TAMSULOSIN HCL 339 320 18 33
HYDROCHLOROTHIAZIDE 337 278 19 10
CRESTOR 336 251 20 21
METOPROLOL TARTRATE 311 260 21 8
LOVASTATIN 299 255 22 20
PROAIR HFA 292 217 23 54
ATORVASTATIN CALCIUM 280 214 24 15
WARFARIN SODIUM 280 254 24 18
TRIAMTERENE-HCTZ 279 244 26 66
SERTRALINE HCL 275 233 27 28
PANTOPRAZOLE SODIUM 275 241 27 45
CAPTOPRIL 269 215 29 213
GLIPIZIDE 269 202 29 40
ALLOPURINOL 266 243 31 35
RANITIDINE HCL 239 186 32 27
ZOLPIDEM TARTRATE 237 185 33 12
CARVEDILOL 236 194 34 23
CLOPIDOGREL 195 162 35 30
TEMAZEPAM 191 177 36 56
PLAVIX 190 160 37 42
GLYBURIDE 178 159 R 38 55
POTASSIUM CHLORIDE 172 156 39 24
SPIRIVA 164 160 40 87
CYMBALTA 157 125 41 73
OXYBUTYNIN CHLORIDE 155 138 42 104
ADVAIR DISKUS 144 125 43 47
DIGOXIN 137 113 44 58
ACARBOSE 133 80 45 422
FLUTICASONE PROPIONATE 132 101 46 32
OXYCODONE HCL-ACETAMINOPHEN 125 101 S2 47 82
VIAGRA 118 102 48 84
DONEPEZIL HCL 118 118 48 31
CLONIDINE HCL 117 74 50 41
ISOSORBIDE MONONITRATE ER 117 116 50 61
LORAZEPAM 115 88 52 98
HYDRALAZINE HCL 111 108 53 107
PREDNISONE 102 95 54 49
IBUPROFEN 100 85 55 43
ENALAPRIL MALEATE 99 66 56 38
NIFEDIPINE ER 98 96 57 75
TRAZODONE HCL 96 57 58 53
NAPROXEN 95 87 59 68
PAROXETINE HCL 95 79 59 62
KLOR-CON 10 92 80 61 114
OXYCODONE-ACETAMINOPHEN 88 53 S2 62 93
AMITRIPTYLINE HCL 82 37 R 63 90
AMOX TR-POTASSIUM CLAVULANATE 80 62 64 138
FINASTERIDE 75 68 65 79
VENLAFAXINE HCL ER 73 67 66 178
TRIAMTERENE-HYDROCHLOROTHIAZID 72 46 67 231
FLUOXETINE HCL 71 52 68 60
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 55 68 102
INSULIN SYRINGE 70 56 70 91
LANTUS 67 25 71 57
CITALOPRAM HBR 67 32 71 25
CARTIA XT 67 67 71 299
BUPROPION HCL SR 63 50 74 207
RAMIPRIL 62 45 75 92
AVODART 60 60 76 180
RISPERIDONE 60 30 76 83
SYMBICORT 58 47 78 160
AMIODARONE HCL 58 39 78 269
CIPROFLOXACIN HCL 57 43 80 52
SYNTHROID 57 42 80 51
TERAZOSIN HCL 52 52 82 115
ESCITALOPRAM OXALATE 50 33 83 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.